STAGE III OVARIAN CANCER AJCC V6 AND V7
Clinical trials for STAGE III OVARIAN CANCER AJCC V6 AND V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III OVARIAN CANCER AJCC V6 AND V7 trials appear
Sign up with your email to follow new studies for STAGE III OVARIAN CANCER AJCC V6 AND V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for ovarian cancer: immune-boosting drug combined with chemo
Disease control OngoingThis early-phase study tested whether adding the immunotherapy drug durvalumab to standard chemotherapy (carboplatin and paclitaxel) helps control advanced ovarian, fallopian tube, or primary peritoneal cancer. 18 women with stage III or IV cancer took part. The goal was to see h…
Matched conditions: STAGE III OVARIAN CANCER AJCC V6 AND V7
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 03:24 UTC
-
Heated chemo during surgery may fight recurrent ovarian cancer
Disease control OngoingThis early-phase study tests the safety and effectiveness of giving heated chemotherapy directly into the abdomen during surgery for advanced or recurrent ovarian, fallopian tube, uterine, or peritoneal cancer. About 40 participants will receive this treatment, with some also get…
Matched conditions: STAGE III OVARIAN CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Ovarian cancer drug study aims to unlock DNA secrets before surgery
Knowledge-focused OngoingThis early-phase study is testing a drug called adavosertib in women with advanced ovarian, fallopian tube, or peritoneal cancer before they have surgery to remove tumors. The goal is to see how the drug changes the DNA of cancer cells, which may help doctors plan more effective …
Matched conditions: STAGE III OVARIAN CANCER AJCC V6 AND V7
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 11, 2026 20:53 UTC